Related Experiment Video
Updated: May 19, 2026
08:08
Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Miniaturization of mechanical circulatory support systems
Guruprasad A Giridharan1, Thomas J Lee, Mickey Ising
1Departments of Bioengineering & Surgery, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY, USA.
Artificial Organs
|August 14, 2012
Summary
Advancements in mechanical circulatory support (MCS) devices, including miniaturization and improved energy transfer, aim to reduce invasiveness and costs for heart failure (HF) patients. Future ventricular assist device technology promises wider applications for HF treatment and myocardial recovery.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Medical Devices
Background:
- Heart failure (HF) is a growing global health concern with significant resource and cost burdens.
- Despite medical advances, HF prognosis remains poor, particularly in advanced stages.
- Current mechanical circulatory support (MCS) devices, while vital, involve invasive surgery and associated adverse events.
Purpose of the Study:
- To explore how miniaturized MCS devices and advanced energy transfer systems can overcome current limitations.
- To enable less invasive surgical procedures for heart failure treatment.
- To improve patient outcomes, quality of life, and reduce healthcare costs.
Main Methods:
- Focus on the technological advancements in MCS device miniaturization.
- Development of efficient and reliable transcutaneous energy transfer systems.
- Anticipation of future ventricular assist device (VAD) technology evolution.
Main Results:
- Miniaturization and improved energy transfer offer potential for less invasive implantation.
- Reduced need for cardiopulmonary bypass and blood component exposure.
- Potential for decreased costs and improved patient recovery and quality of life.
Conclusions:
- Technological innovations in MCS are poised to revolutionize heart failure therapy.
- Future VADs may support myocardial recovery and cell therapy, expanding treatment options.
- Less invasive MCS implantation can lead to better patient outcomes and broader therapeutic applications.
